Finding innovative solutions for unmet medical needs is at the heart of what we do. Our ideas and research help save lives.
Cardiometabolic diseases are one of the greatest challenges we face. Our focus lies in countering the threat through innovative diagnostic, therapies and preventive solutions.
More than 500 million people are affected by the global diabetes epidemic. We are working to personalise daily diabetes management to make their lives easier.
Haematology is a complex and challenging area of medicine. At Roche, finding innovative solutions for those affected by diseases of the blood is a priority.
The infectious disease landscape is ever-changing with outbreaks, mutations, emerging pathogens, and growing resistances placing pressures on healthcare systems. Roche is determined to provide relief and care.
Uncovering the full picture of inflammatory bowel diseases, one piece at a time.
Together, we dare to transform lives by building on our long-standing expertise in immunology to address unmet needs across the spectrum of kidney diseases.
We're pushing boundaries of scientific understanding to achieve clinical advancements and solve some of the greatest challenges in neuroscience today— to preserve what makes us who we are.
Our scientists take a rigorous, comprehensive approach to understanding cancer biology and drug discovery.
We are focused on pioneering therapies to prevent vision loss, working to discover and develop innovative solutions, aiming to redefine standards of care for people living with of vision impairment.
With nearly 30 years in respiratory research, we are focused on improving outcomes for patients with severe respiratory diseases.
Roche is committed to women’s health at every stage of her life.
Working together to build a better world for people with rare diseases.
At Roche Partnering, we are passionate about science: yours and ours. Through partnerships, we hope that together we can build a better future with medicines that make a real difference to patients.
Clinical trials are essential to determine whether new drugs or diagnostics are safe and effective when used to diagnose or treat people.